<DOC>
	<DOCNO>NCT01827137</DOCNO>
	<brief_summary>The purpose study see investigator help immune system work myeloma . Because cancer produce patient body , immune system easily recognize fight cancer cell . The immune system need `` trained '' . This disease select study Wilms Tumor 1 ( WT1 ) protein often present myeloma cell . WT1 gene involve normal development kidney organ . When WT1 gene become abnormal , make protein involve development cancer . This study determine whether WT1 vaccine cause immune response safe able keep myeloma come back .</brief_summary>
	<brief_title>WT1 Analog Peptide Vaccine Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<criteria>Symptomatic multiple myeloma , ISS stage 13 confirm diagnosis multiple myeloma MSKCC Patients must eligible undergo autologous stem cell transplantation standard institutional criterion Patients must document WT1 positive disease . For purpose study , define detectable presence WT1 expression immunohistochemistry WT1 transcript via RTPCR bone marrow plasma cellrelated biopsy specimen prior autologous stem cell transplantation . Bone marrow biopsy specimen time diagnosis patient diagnose MSKCC outside hospital may request assessment WT1 expression IHC Age &gt; = 18 year Karnofsky performance status &gt; = 50 % Hematologic parameter : Absolute neutrophil count ( ANC ) &gt; = 1000/μl Platelets &gt; 50k/ μl Biochemical parameter : Total bilirubin &lt; = 2.0 mg/dl AST ALT &lt; = 2.5 x upper limit normal Creatinine &lt; = 2.0 mg/dl Pregnant lactate woman Patients active infection require systemic antimicrobial Patients take systemic corticosteroid Patients serious unstable medical illness Concurrent malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>WT1 Analog Peptide Vaccine</keyword>
	<keyword>12-288</keyword>
</DOC>